Azivent

Azithromycin

Treatment option:

Medically reviewed

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azivent

What is Azivent?

Azivent is an antibacterial medication used to treat various types of infections caused by bacteria. It belongs to a class of drugs known as macrolide antibiotics. These medications work by interfering with the ability of bacteria to produce essential proteins, which effectively prevents the growth and spread of the infection within the body.

Therapeutic Use

This medication is primarily used to address bacterial infections in different parts of the body. Because it targets specific biological processes in bacteria, it is not effective against viral infections such as the common cold or the flu.

Commonly treated conditions include:

Respiratory tract infections: Such as bronchitis and certain types of pneumonia.
Sinus and throat infections: Including sinusitis and tonsillitis.
Skin infections: Various uncomplicated bacterial infections of the skin and underlying tissues.
Middle ear infections: Often used in pediatric and adult cases.
Sexually transmitted infections: Specifically those involving the urethra or cervix caused by susceptible organisms.

How it Functions

Azivent contains the active substance azithromycin. As a macrolide antibiotic, it is bacteriostatic, meaning it inhibits the multiplication of bacteria rather than killing them outright immediately. By binding to the 50S subunit of the bacterial ribosome, it prevents the translation of mRNA, which halts protein synthesis. Without these proteins, the bacteria cannot maintain their structure or reproduce, allowing the body's immune system to clear the remaining infection.

Regulatory References

What side effects are possible with Azivent?

Possible Side Effects and Safety Information

Azivent (azithromycin) is a macrolide antibiotic with a distinct safety profile that includes both common gastrointestinal disturbances and several serious, though rare, warnings concerning the cardiovascular system and liver.

Adverse Reactions and Categorization

Category	Frequency/Description
Most Common	Gastrointestinal disturbances: diarrhea (including loose stools), nausea, abdominal pain, and vomiting. Headache and dizziness may also occur.
Serious Warnings	Cardiovascular Risk: The drug can cause QT interval prolongation, leading to a risk of potentially fatal irregular heart rhythms such as Torsades de pointes and an increased short-term risk of acute cardiovascular death, particularly in patients with existing risk factors.
	Hepatotoxicity: Cases of severe, sometimes fatal, hepatic failure, hepatic necrosis, and cholestatic jaundice have been reported. Immediate discontinuation is required if signs of liver injury appear.
	Hypersensitivity: Serious allergic reactions, including anaphylaxis, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS syndrome, have been documented.
	C. difficile-Associated Diarrhea (CDAD) and exacerbation of myasthenia gravis are also serious, documented risks.

Population-Specific Safety Notes

Neonates (up to 42 days of life): Use has been associated with the risk of Infantile Hypertrophic Pyloric Stenosis (IHPS).
Elderly Patients: May be more susceptible to the development of the dangerous Torsades de pointes arrhythmia.
Contraindication: Azivent is contraindicated in patients with a prior history of cholestatic jaundice or hepatic dysfunction associated with previous use of azithromycin.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Azithromycin (the active ingredient in Azivent) specifies the symptoms and required management in the event of an overdose. Overexposure typically results in an intensification of known side effects.

Documented Overdose Presentations

Symptoms reported after the intake of doses exceeding recommended levels are consistent with known adverse reactions. These include:

Severe gastrointestinal distress: Manifestations such as nausea, vomiting, and diarrhea.
Hearing impairment: Temporary or reversible hearing loss.

Required Emergency Actions

Immediate medical help must be sought if an overdose is suspected. Regulatory labeling specifies the following measures are required:

Action Type	Regulatory Indication
Decontamination	Administration of medicinal (activated) charcoal is indicated.
Support	General symptomatic treatment and supportive measures are required.

Since there is no specific regulatory-approved antidote, the core treatment focuses on limiting absorption and managing acute symptoms to stabilize the patient. The occurrence of severe symptoms and the need for specific medical procedures, such as charcoal administration, define when urgent professional help is necessary.

Therapeutic Uses of Azivent

Azithromycin (Azivent) is a macrolide antibacterial drug that is relevant in contexts where short-term symptomatic assistance is needed for infections caused by susceptible bacteria. This plays a role in managing infections across several body systems.

Its core therapeutic domain is applied in addressing bacterial infections. This supports patients during episodes of heightened discomfort associated with respiratory conditions like acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia, which are conditions characterized by periods of heightened symptoms such as persistent cough.

Azithromycin is commonly used for easing symptoms related to inflammatory or irritative states in other areas as well. Key indications for which it is commonly used to help with include acute bacterial sinusitis, uncomplicated skin and skin structure infections, pharyngitis/tonsillitis, and specific sexually transmitted infections like urethritis and cervicitis. The medicine may assist with maintaining functional stability by helping to address the source of these disruptive symptom patterns.

“The medicine is commonly used to help with managing a variety of susceptible bacterial infections.”

Quick Fact: Relief for Physical Discomfort

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Azivent (Azithromycin) — Official Regulatory Information

The eligibility for Azivent is strictly defined by government health authorities based on patient factors, prior reactions, and underlying conditions. Eligibility is categorized into absolute prohibitions and conditional use.

Eligibility Scope

Category	Regulatory Status
Populations for whom use is allowed	Adults; Pediatric patients ge 6 months of age (for most approved oral forms).
Populations for whom use is contraindicated	Known hypersensitivity to Azithromycin, macrolides, or ketolides; History of cholestatic jaundice or hepatic dysfunction associated with prior Azithromycin use.
Age-related eligibility rules	Safety and effectiveness have not been established for infants under 6 months. Caution is advised for infants (treatment le 42 days) due to IHPS risk.
Condition-specific eligibility rules	Caution is advised for patients with pre-existing risk factors for QT interval prolongation (e.g., severe bradycardia, uncorrected low potassium) and those with severe renal or hepatic impairment.
Pregnancy and lactation status	Use during pregnancy is permitted only if clearly needed. Caution is advised during lactation.

Official Eligibility Structure

The regulatory profile prohibits use (is contraindicated) in patients with specific prior drug reactions and allergies, preventing use in these populations. Eligibility is further restricted by requiring caution for conditions that impair drug elimination (severe organ failure) or increase cardiac risk, and by noting that safety is not established for infants younger than 6 months.

What should I know about interactions with other medicines?

Azivent Interactions with other medicines and products

Azivent (azithromycin) can interact with several other medications, potentially altering the effect of either drug or increasing the risk of adverse reactions. It is crucial to inform your healthcare provider about all prescription drugs, non-prescription medicines, and herbal supplements you are taking.

Drug Type	Example Medications	Potential Interaction	Management
Anticoagulants (Blood Thinners)	Warfarin	Increased risk of bleeding; effect of the anticoagulant may be potentiated.	Close monitoring of blood clotting time (INR) is essential.
Cardiac Glycosides	Digoxin	Increased digoxin levels in the blood, raising the risk of toxicity (e.g., severe heart rhythm problems, nausea).	Digoxin blood levels should be monitored closely.
Immunosuppressants	Cyclosporine	Azithromycin may rarely increase cyclosporine blood levels.	Monitoring of cyclosporine levels is advised to prevent toxicity.
HIV Medication	Nelfinavir	Increased azithromycin levels in the blood.	Close monitoring for increased azithromycin side effects (e.g., hearing impairment, liver problems).

Other Important Interactions

Antacids: Medications containing aluminum or magnesium (used for indigestion or heartburn) can significantly reduce the absorption and effectiveness of Azivent. To avoid this, take Azivent at least two hours before or two hours after taking an antacid.
QT Prolongation: Azithromycin itself carries a risk of altering the heart's electrical activity (QT prolongation). Using it with other medicines that also prolong the QT interval, such as certain antiarrhythmics, antipsychotics, or some other antibiotics, increases the risk of a serious, potentially life-threatening irregular heartbeat.
Statins: While generally considered a lower risk than with other macrolides, the combination of azithromycin and certain statins (cholesterol-lowering drugs) may rarely increase the risk of muscle damage (rhabdomyolysis).

Always discuss your complete medical history and current medication list with your doctor or pharmacist to manage potential interactions safely.

Mechanism of Action

Inhibiting Foreign Cell Replication

Azivent exerts its primary effect by acting as an inhibitor on the 50S ribosomal subunit of susceptible foreign cells. This molecular binding blocks the cell's ability to complete protein synthesis, which is essential for growth and division, contributing to the inhibition of foreign cell proliferation.

Targeted Tissue Concentration

The drug is designed to selectively accumulate within specific immune cells and tissues, resulting in high, sustained concentrations at the site of concern. This targeted accumulation supports the sustained local inhibition of foreign cell activity within the tissue microenvironment.

Modulating the Immune Response

Beyond its main inhibitory action, Azivent also acts as a modulator by influencing the activity of immune cells and the release of specific inflammatory mediators (cytokines). This secondary mechanism helps to dampen or normalize the body's excessive local inflammatory response, influencing the local environment to promote regulated physiological response.

Dosage and Administration Information

How to Use Azivent

Azivent (Azithromycin) is used according to specific, standardized protocols for the duration, frequency, and administration route. The medicine's unique pharmacokinetic profile supports once-daily dosing for most systemic regimens, contrasting with the frequent dosing required for earlier macrolides.

Official Administration and Dosage Protocols

Instruction Entity	Official Guideline
Route of Administration	Primarily Oral (tablets, suspension). Also approved for Intravenous (IV) infusion for initial therapy in severe infections.
Standard Dosing Schedules	Most acute infections utilize a 1500 mg total course administered over 3 days (500 mg once daily) or 5 days (500 mg Day 1, then 250 mg Days 2-5). A 1 g single dose is prescribed for specific indications.
Timing in Relation to Meals	Standard oral forms may be taken with or without food. However, certain extended-release oral formulations are instructed to be taken on an empty stomach to ensure proper absorption.
Frequency Pattern	Once daily for systemic treatment courses (e.g., 3- or 5-day protocols). A once-weekly frequency is used for long-term prophylaxis of Mycobacterium avium Complex.
Pediatric Dosing Principle	Dosing for children >= 6 months is strictly determined on a body-weight basis (mg/kg), using 1-, 3-, or 5-day regimens.
Special Procedural Conditions	Intravenous administration must be performed as a slow infusion over either 1 hour or 3 hours (depending on the final concentration), and must not be administered as a bolus injection.

General Usage Principles

These official instructions define the structured, time-bound protocol for Azivent's administration. The necessity for the oral versus intravenous route dictates the setting of use, and the specific daily frequency must be adhered to for the entire course duration. If a dose is missed, instructions advise the patient to take the missed dose immediately and then take the next dose at the regularly scheduled time.

Recent Clinical Evidence

Azivent (azithromycin) is a macrolide antibiotic approved for specific bacterial infections. Clinical studies in respiratory medicine have focused on its use in acute bacterial infections and its potential long-term, low-dose role in chronic airway diseases, including its non-antibiotic properties.

Acute Respiratory Infections

Clinical trials support the use of azithromycin for certain bacterial respiratory infections, such as community-acquired pneumonia (CAP) caused by susceptible organisms, including atypical pathogens like Mycoplasma pneumoniae and Chlamydophila pneumoniae. Observational data for hospitalized CAP patients suggest that azithromycin, when combined with a beta-lactam, may be associated with favorable outcomes, including lower in-hospital mortality and an increase in hospital-free days, compared to a doxycycline-based regimen in combination with a beta-lactam. However, clinical evidence strongly indicates that azithromycin is not beneficial for most acute respiratory tract infections, which are predominantly viral, such as the common cold or flu, and its use in such cases is discouraged due to concerns about promoting antimicrobial resistance.

Chronic Respiratory Conditions

Research has explored the use of long-term, low-dose azithromycin, sometimes referred to as maintenance therapy, in certain chronic obstructive pulmonary disease (COPD) and non-cystic fibrosis bronchiectasis patients with frequent exacerbations. Large randomized controlled trials (RCTs) indicate that a course of long-term therapy may reduce the annual rate of acute exacerbations and increase the time interval between them in certain patient populations. The mechanism for this observed effect in chronic diseases is not fully understood but is thought to involve the drug's non-antibiotic, immunomodulatory properties rather than solely its antibacterial action. This prophylactic use is subject to ongoing research and careful risk-benefit consideration due to the potential for increased antimicrobial resistance and rare cardiac adverse events.

Key Studies & References

How should Azivent be stored and disposed of?

How to Store and Dispose of Azivent?

Azivent (azithromycin) must be stored and handled according to specific regulatory guidelines. Tablets and the dry powder for oral suspension should be kept at controlled room temperature, generally below 86 F (30 C), and away from excess heat and moisture.

Handling and Stability:

Keep the medication in its original, tightly closed container and out of the reach of children.
Do not freeze the oral suspension.
The regular oral suspension must be discarded 10 days after reconstitution, and the extended-release suspension must be discarded after 12 hours.

Disposal:

Dispose of expired or unused Azivent by following FDA guidelines. This includes utilizing drug take-back programs or, if unavailable, mixing the medicine with an undesirable substance (like dirt or coffee grounds) and sealing it in a container before placing it in the household trash. Do not flush this medication down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z